世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

糖尿病検査プログラムの世界市場インサイト、2030年までの予測


Global Diabetes Testing Program Market Insights, Forecast to 2030

糖尿病検査プログラムの世界市場は、2024年の25億420万米ドルから2030年には38億7215万米ドルに成長すると予測され、予測期間中の年間平均成長率（CAGR）は7.53％と予測される。 米国とカナダの糖尿病検査プログ... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2024年3月20日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

糖尿病検査プログラムの世界市場は、2024年の25億420万米ドルから2030年には38億7215万米ドルに成長すると予測され、予測期間中の年間平均成長率（CAGR）は7.53％と予測される。
米国とカナダの糖尿病検査プログラム市場は、2025年から2030年の予測期間中にCAGR 7.34%で、2024年の5億302万ドルから2030年には7億6948万ドルに達すると推定される。
糖尿病検査プログラムの中国市場は、2024年の8億4,284万ドルから2030年には13億3,716万ドルに達すると推定され、2025年から2030年の予測期間中のCAGRは8.00%である。
糖尿病検査プログラムのヨーロッパ市場は、2025年から2030年の予測期間中に6.19％のCAGRで、2024年に3億1,203万ドルから増加し、2030年には4億4,737万ドルに達すると推定される。
糖尿病検査プログラムの世界的な主要メーカーは、アボットラボラトリーズ、ロシュ、シーメンス、ライフスキャン、バイオラッドラボラトリーズなどが含まれます。2023年、世界の上位5社の売上高シェアは約64.41％であった。

レポートの内容
糖尿病検査プログラムの世界市場概要、売上高、収益、価格を紹介します。2019年～2023年の過去の市場収益/売上データ、2024年の予測、2030年までのCAGR予測による世界市場動向の分析。
糖尿病検査プログラムの主要生産者を調査し、主要地域・国の売上高も掲載しています。糖尿病検査プログラムの今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点のハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、糖尿病検査プログラムの売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当て、2019年から2024年までのデータを掲載しています。世界の糖尿病検査プログラム市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。

本レポートでは、2019年から2030年までのセグメントデータをタイプ別、用途別、売上高、収益、価格で分析しています。糖尿病検査プログラムの売上高、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
Roche、LifeScan、Abbott Laboratories、Ascensia、Arkray、I-SENS、Omron、Braun、Siemensなど、世界の主要企業の詳細な企業プロフィール。

市場セグメンテーション
企業別
アボット研究所
ロシュ
シーメンス
ライフスキャン
バイオ・ラッド・ラボラトリーズ
シノケア
東ソー
アセンシア
ダナハーコーポレーション
トリニティ・バイオテック
アコン・バイオテック
テルモ
アークレイ
ヒューマン・ダイアグノスティックス
ブラウン
アイセンス
オムロン

タイプ別セグメント
HbA1c検査
フィンガープリックテスト

アプリケーション別
医療診断
在宅検査
ラボ検査

地域別セグメント
米国・カナダ
米国
カナダ
中国

アジア（中国を除く）
日本
韓国
東南アジア
インド
オーストラリア

ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア

中東、アフリカ、中南米
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

各章の概要
第1章：報告書のスコープ、各市場セグメント（タイプ別、用途別など）の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章 糖尿病検査プログラムの世界、地域レベル、国レベルでの販売（消費）、収益各地域と主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間を紹介します。
第3章：糖尿病検査プログラムメーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析。
第4章：タイプ別に様々な市場セグメントを分析し、各市場セグメントの売上高、収益、平均価格、発展の可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。
第5章：読者が異なる川下市場におけるブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーする、アプリケーション別の様々な市場セグメントの分析を提供します。
第6章 北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。
第7章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章：中国：タイプ別、用途別、セグメント別の売上高、収益。
第9章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。
第10章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。
第11章：主要メーカーのプロファイルを提供し、製品の説明と仕様、糖尿病検査プログラムの売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第12章：産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。
第13章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第14章：レポートの要点と結論。



ページTOPに戻る


目次

1 STUDY COVERAGE 1
1.1 Diabetes Testing Program Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Diabetes Testing Program Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 2
1.2.2 HbA1c Test 4
1.2.3 Finger-prick Test 5
1.3 Market by Application 5
1.3.1 Global Diabetes Testing Program Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 6
1.3.2 Medical Diagnosis 7
1.3.3 Home Test 8
1.3.4 Lab Testing 8
1.4 Assumptions and Limitations 9
1.5 Study Objectives 10
1.6 Years Considered 11
2 EXECUTIVE SUMMARY 12
2.1 Global Diabetes Testing Program Revenue Estimates and Forecasts 2019-2030 12
2.2 Global Diabetes Testing Program Revenue by Region 13
2.2.1 Global Diabetes Testing Program Revenue by Region: 2019 VS 2023 VS 2030 13
2.2.2 Global Diabetes Testing Program Revenue by Region (2019-2024) 15
2.2.3 Global Diabetes Testing Program Revenue by Region (2025-2030) 16
2.2.4 Global Diabetes Testing Program Revenue Market Share by Region (2019-2030) 16
2.3 Global Diabetes Testing Program Sales Estimates and Forecasts 2019-2030 17
2.4 Global Diabetes Testing Program Sales by Region 18
2.4.1 Global Diabetes Testing Program Sales by Region: 2019 VS 2023 VS 2030 18
2.4.2 Global Diabetes Testing Program Sales by Region (2019-2024) 19
2.4.3 Global Diabetes Testing Program Sales by Region (2025-2030) 19
2.4.4 Global Diabetes Testing Program Sales Market Share by Region (2019-2030) 20
2.5 US & Canada 21
2.6 Europe 22
2.7 China 23
2.8 Asia (excluding China) 24
2.9 Middle East, Africa and Latin America 25
3 COMPETITION BY MANUFACTURERS 27
3.1 Global Diabetes Testing Program Sales by Manufacturers 27
3.1.1 Global Diabetes Testing Program Sales by Manufacturers (2019-2024) 27
3.1.2 Global Diabetes Testing Program Sales Market Share by Manufacturers (2019-2024) 28
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diabetes Testing Program in 2023 29
3.2 Global Diabetes Testing Program Revenue by Manufacturers 31
3.2.1 Global Diabetes Testing Program Revenue by Manufacturers (2019-2024) 31
3.2.2 Global Diabetes Testing Program Revenue Market Share by Manufacturers (2019-2024) 32
3.2.3 Global Top 10 and Top 5 Companies by Diabetes Testing Program Revenue in 2023 33
3.3 Global Key Players of Diabetes Testing Program, Industry Ranking, 2021 VS 2022 34
3.4 Global Diabetes Testing Program Sales Price by Manufacturers (2019-2024) 35
3.5 Analysis of Competitive Landscape 36
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 36
3.5.2 Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 37
3.6 Global Key Manufacturers of Diabetes Testing Program, Manufacturing Base Distribution and Headquarters 39
3.7 Global Key Manufacturers of Diabetes Testing Program, Product Offered 39
3.8 Global Key Manufacturers of Diabetes Testing Program, Date of Enter into This Industry 40
3.9 Mergers & Acquisitions, Expansion Plans 41
4 MARKET SIZE BY TYPE 43
4.1 Global Diabetes Testing Program Sales by Type 43
4.1.1 Global Diabetes Testing Program Historical Sales by Type (2019-2024) 43
4.1.2 Global Diabetes Testing Program Forecasted Sales by Type (2025-2030) 43
4.1.3 Global Diabetes Testing Program Sales Market Share by Type (2019-2030) 44
4.2 Global Diabetes Testing Program Revenue by Type 45
4.2.1 Global Diabetes Testing Program Historical Revenue by Type (2019-2024) 45
4.2.2 Global Diabetes Testing Program Forecasted Revenue by Type (2025-2030) 45
4.2.3 Global Diabetes Testing Program Revenue Market Share by Type (2019-2030) 45
4.3 Global Diabetes Testing Program Price by Type 46
4.3.1 Global Diabetes Testing Program Price by Type (2019-2024) 46
4.3.2 Global Diabetes Testing Program Price Forecast by Type (2025-2030) 47
5 MARKET SIZE BY APPLICATION 48
5.1 Global Diabetes Testing Program Sales by Application 48
5.1.1 Global Diabetes Testing Program Historical Sales by Application (2019-2024) 48
5.1.2 Global Diabetes Testing Program Forecasted Sales by Application (2025-2030) 48
5.1.3 Global Diabetes Testing Program Sales Market Share by Application (2019-2030) 49
5.2 Global Diabetes Testing Program Revenue by Application 50
5.2.1 Global Diabetes Testing Program Historical Revenue by Application (2019-2024) 50
5.2.2 Global Diabetes Testing Program Forecasted Revenue by Application (2025-2030) 50
5.2.3 Global Diabetes Testing Program Revenue Market Share by Application (2019-2030) 50
5.3 Global Diabetes Testing Program Price by Application 52
5.3.1 Global Diabetes Testing Program Price by Application (2019-2024) 52
5.3.2 Global Diabetes Testing Program Price Forecast by Application (2025-2030) 52
6 US & CANADA 53
6.1 US & Canada Diabetes Testing Program Market Size by Type 53
6.1.1 US & Canada Diabetes Testing Program Sales by Type (2019-2030) 53
6.1.2 US & Canada Diabetes Testing Program Revenue by Type (2019-2030) 54
6.2 US & Canada Diabetes Testing Program Market Size by Application 55
6.2.1 US & Canada Diabetes Testing Program Sales by Application (2019-2030) 55
6.2.2 US & Canada Diabetes Testing Program Revenue by Application (2019-2030) 56
6.3 US & Canada Diabetes Testing Program Market Size by Country 58
6.3.1 US & Canada Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030 58
6.3.2 US & Canada Diabetes Testing Program Revenue by Country (2019-2030) 58
6.3.3 US & Canada Diabetes Testing Program Sales by Country (2019-2030) 59
6.3.4 US 60
6.3.5 Canada 61
7 EUROPE 62
7.1 Europe Diabetes Testing Program Market Size by Type 62
7.1.1 Europe Diabetes Testing Program Sales by Type (2019-2030) 62
7.1.2 Europe Diabetes Testing Program Revenue by Type (2019-2030) 63
7.2 Europe Diabetes Testing Program Market Size by Application 64
7.2.1 Europe Diabetes Testing Program Sales by Application (2019-2030) 64
7.2.2 Europe Diabetes Testing Program Revenue by Application (2019-2030) 65
7.3 Europe Diabetes Testing Program Market Size by Country 66
7.3.1 Europe Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030 66
7.3.2 Europe Diabetes Testing Program Revenue by Country (2019-2030) 67
7.3.3 Europe Diabetes Testing Program Sales by Country (2019-2030) 68
7.3.4 Germany 70
7.3.5 France 70
7.3.6 U.K. 71
7.3.7 Italy 71
7.3.8 Russia 72
8 CHINA 73
8.1 China Diabetes Testing Program Market Size by Type 73
8.1.1 China Diabetes Testing Program Sales by Type (2019-2030) 73
8.1.2 China Diabetes Testing Program Revenue by Type (2019-2030) 74
8.2 China Diabetes Testing Program Market Size by Application 75
8.2.1 China Diabetes Testing Program Sales by Application (2019-2030) 75
8.2.2 China Diabetes Testing Program Revenue by Application (2019-2030) 76
9 ASIA (EXCLUDING CHINA) 78
9.1 Asia Diabetes Testing Program Market Size by Type 78
9.1.1 Asia Diabetes Testing Program Sales by Type (2019-2030) 78
9.1.2 Asia Diabetes Testing Program Revenue by Type (2019-2030) 79
9.2 Asia Diabetes Testing Program Market Size by Application 80
9.2.1 Asia Diabetes Testing Program Sales by Application (2019-2030) 80
9.2.2 Asia Diabetes Testing Program Revenue by Application (2019-2030) 81
9.3 Asia Diabetes Testing Program Market Size by Region 82
9.3.1 Asia Diabetes Testing Program Revenue by Region: 2019 VS 2023 VS 2030 82
9.3.2 Asia Diabetes Testing Program Revenue by Region (2019-2030) 82
9.3.3 Asia Diabetes Testing Program Sales by Region (2019-2030) 83
9.3.4 Japan 85
9.3.5 South Korea 85
9.3.6 Southeast Asia 86
9.3.7 India 86
9.3.8 Australia 87
10 MIDDLE EAST, AFRICA AND LATIN AMERICA 88
10.1 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Type 88
10.1.1 Middle East, Africa and Latin America Diabetes Testing Program Sales by Type (2019-2030) 88
10.1.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Type (2019-2030) 89
10.2 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Application 90
10.2.1 Middle East, Africa and Latin America Diabetes Testing Program Sales by Application (2019-2030) 90
10.2.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Application (2019-2030) 91
10.3 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Country 93
10.3.1 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030 93
10.3.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country (2019-2030) 93
10.3.3 Middle East, Africa and Latin America Diabetes Testing Program Sales by Country (2019-2030) 95
10.3.4 Brazil 96
10.3.5 Mexico 97
10.3.6 Turkey 97
10.3.7 Israel 98
10.3.8 GCC Countries 98
11 CORPORATE PROFILE 99
11.1 Abbott Laboratories 99
11.1.1 Abbott Laboratories Company Information 99
11.1.2 Abbott Laboratories Overview 99
11.1.3 Abbott Laboratories Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 100
11.1.4 Abbott Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 100
11.1.5 Abbott Laboratories Recent Developments 101
11.2 Roche 102
11.2.1 Roche Company Information 102
11.2.2 Roche Overview 102
11.2.3 Roche Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 103
11.2.4 Roche Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 103
11.2.5 Roche Recent Developments 105
11.3 Siemens 106
11.3.1 Siemens Company Information 106
11.3.2 Siemens Overview 106
11.3.3 Siemens Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 107
11.3.4 Siemens Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 108
11.3.5 Siemens Recent Developments 108
11.4 LifeScan 109
11.4.1 LifeScan Company Information 109
11.4.2 LifeScan Overview 110
11.4.3 LifeScan Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 110
11.5 Bio-Rad Laboratories 111
11.5.1 Bio-Rad Laboratories Company Information 112
11.5.2 Bio-Rad Laboratories Overview 112
11.5.3 Bio-Rad Laboratories Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 113
11.5.4 Bio-Rad Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 113
11.5.5 Bio-Rad Laboratories Recent Developments 114
11.6 Sinocare 114
11.6.1 Sinocare Company Information 114
11.6.2 Sinocare Overview 115
11.6.3 Sinocare Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 115
11.6.4 Sinocare Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 116
11.7 Tosoh 117
11.7.1 Tosoh Company Information 118
11.7.2 Tosoh Overview 118
11.7.3 Tosoh Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 119
11.7.4 Tosoh Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 120
11.7.5 Tosoh Recent Developments 120
11.8 Ascensia 121
11.8.1 Ascensia Company Information 121
11.8.2 Ascensia Overview 122
11.8.3 Ascensia Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 122
11.8.4 Ascensia Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 123
11.9 Danaher Corporation 124
11.9.1 Danaher Corporation Company Information 124
11.9.2 Danaher Corporation Overview 125
11.9.3 Danaher Corporation Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 126
11.9.4 Danaher Corporation Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 126
11.9.5 Danaher Corporation Recent Developments 127
11.10 Trinity Biotech 128
11.10.1 Trinity Biotech Company Information 128
11.10.2 Trinity Biotech Overview 128
11.10.3 Trinity Biotech Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 130
11.10.4 Trinity Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 130
11.10.5 Trinity Biotech Recent Developments 131
11.11 Acon Biotech 132
11.11.1 Acon Biotech Company Information 132
11.11.2 Acon Biotech Overview 132
11.11.3 Acon Biotech Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 133
11.11.4 Acon Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 133
11.12 Terumo 134
11.12.1 Terumo Company Information 135
11.12.2 Terumo Overview 135
11.12.3 Terumo Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 136
11.12.4 Terumo Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 137
11.12.5 Terumo Recent Developments 138
11.13 Arkray 139
11.13.1 Arkray Company Information 139
11.13.2 Arkray Overview 139
11.13.3 Arkray Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 140
11.13.4 Arkray Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 140
11.14 HUMAN Diagnostics 142
11.14.1 HUMAN Diagnostics Company Information 142
11.14.2 HUMAN Diagnostics Overview 142
11.14.3 HUMAN Diagnostics Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 143
11.14.4 HUMAN Diagnostics Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 143
11.15 Braun 144
11.15.1 Braun Company Information 144
11.15.2 Braun Overview 145
11.15.3 Braun Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 145
11.15.4 Braun Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 146
11.15.5 Braun Recent Developments 147
11.16 I-SENS 147
11.16.1 I-SENS Company Information 147
11.16.2 I-SENS Overview 148
11.16.3 I-SENS Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 148
11.16.4 I-SENS Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 148
11.16.5 I-SENS Recent Developments 149
11.17 Omron 150
11.17.1 Omron Company Information 150
11.17.2 Omron Overview 150
11.17.3 Omron Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 151
11.17.4 Omron Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 151
11.17.5 Omron Recent Developments 152
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 154
12.1 Diabetes Testing Program Industry Chain Analysis 154
12.2 Diabetes Testing Program Key Raw Materials 155
12.2.1 Key Raw Materials 155
12.2.2 Raw Materials Key Suppliers 155
12.3 Diabetes Testing Program Production Mode & Process 156
12.4 Diabetes Testing Program Sales and Marketing 157
12.4.1 Diabetes Testing Program Sales Channels 157
12.4.2 Diabetes Testing Program Distributors 157
12.5 Diabetes Testing Program Customers 158
13 DIABETES TESTING PROGRAM MARKET DYNAMICS 159
13.1.1 Diabetes Testing Program Industry Trends 159
13.1.2 Diabetes Testing Program Market Drivers 160
13.1.3 Diabetes Testing Program Market Challenges 161
13.1.4 Diabetes Testing Program Market Restraints 162
14 KEY FINDINGS IN THE GLOBAL DIABETES TESTING PROGRAM STUDY 163
15 APPENDIX 164
15.1 Research Methodology 164
15.1.1 Methodology/Research Approach 164
15.1.2 Data Source 167
15.2 Author Details 170
15.3 Disclaimer 170

　

ページTOPに戻る


　

Summary

The global Diabetes Testing Program market is projected to grow from US$ 2,504.20 million in 2024 to US$ 3,872.15 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.53% during the forecast period.
The United States & Canada market for Diabetes Testing Program is estimated to increase from $ 503.02 million in 2024 to reach $ 769.48 million by 2030, at a CAGR of 7.34% during the forecast period of 2025 through 2030.
The China market for Diabetes Testing Program is estimated to increase from $ 842.84 million in 2024 to reach $ 1,337.16 million by 2030, at a CAGR of 8.00% during the forecast period of 2025 through 2030.
The Europe market for Diabetes Testing Program is estimated to increase from $ 312.03 million in 2024 to reach $ 447.37 million by 2030, at a CAGR of 6.19% during the forecast period of 2025 through 2030.
The global key manufacturers of Diabetes Testing Program include Abbott Laboratories, Roche, Siemens, LifeScan, Bio-Rad Laboratories, etc. In 2023, the global top five players had a share approximately 64.41% in terms of revenue.

Report Includes
This report presents an overview of global market for Diabetes Testing Program, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Diabetes Testing Program, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Diabetes Testing Program, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diabetes Testing Program sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Diabetes Testing Program market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Diabetes Testing Program sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche, LifeScan, Abbott Laboratories, Ascensia, Arkray, I-SENS, Omron, Braun, and Siemens, etc.

Market Segmentation
By Company
Abbott Laboratories
Roche
Siemens
LifeScan
Bio-Rad Laboratories
Sinocare
Tosoh
Ascensia
Danaher Corporation
Trinity Biotech
Acon Biotech
Terumo
Arkray
HUMAN Diagnostics
Braun
I-SENS
Omron

Segment by Type
HbA1c Test
Finger-prick Test

Segment by Application
Medical Diagnosis
Home Test
Lab Testing

Segment by Region
US & Canada
U.S.
Canada
China

Asia (excluding China)
Japan
South Korea
Southeast Asia
India
Australia

Europe
Germany
France
U.K.
Italy
Russia

Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Diabetes Testing Program in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Diabetes Testing Program manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Testing Program sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 STUDY COVERAGE 1
1.1 Diabetes Testing Program Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Diabetes Testing Program Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 2
1.2.2 HbA1c Test 4
1.2.3 Finger-prick Test 5
1.3 Market by Application 5
1.3.1 Global Diabetes Testing Program Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 6
1.3.2 Medical Diagnosis 7
1.3.3 Home Test 8
1.3.4 Lab Testing 8
1.4 Assumptions and Limitations 9
1.5 Study Objectives 10
1.6 Years Considered 11
2 EXECUTIVE SUMMARY 12
2.1 Global Diabetes Testing Program Revenue Estimates and Forecasts 2019-2030 12
2.2 Global Diabetes Testing Program Revenue by Region 13
2.2.1 Global Diabetes Testing Program Revenue by Region: 2019 VS 2023 VS 2030 13
2.2.2 Global Diabetes Testing Program Revenue by Region (2019-2024) 15
2.2.3 Global Diabetes Testing Program Revenue by Region (2025-2030) 16
2.2.4 Global Diabetes Testing Program Revenue Market Share by Region (2019-2030) 16
2.3 Global Diabetes Testing Program Sales Estimates and Forecasts 2019-2030 17
2.4 Global Diabetes Testing Program Sales by Region 18
2.4.1 Global Diabetes Testing Program Sales by Region: 2019 VS 2023 VS 2030 18
2.4.2 Global Diabetes Testing Program Sales by Region (2019-2024) 19
2.4.3 Global Diabetes Testing Program Sales by Region (2025-2030) 19
2.4.4 Global Diabetes Testing Program Sales Market Share by Region (2019-2030) 20
2.5 US & Canada 21
2.6 Europe 22
2.7 China 23
2.8 Asia (excluding China) 24
2.9 Middle East, Africa and Latin America 25
3 COMPETITION BY MANUFACTURERS 27
3.1 Global Diabetes Testing Program Sales by Manufacturers 27
3.1.1 Global Diabetes Testing Program Sales by Manufacturers (2019-2024) 27
3.1.2 Global Diabetes Testing Program Sales Market Share by Manufacturers (2019-2024) 28
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diabetes Testing Program in 2023 29
3.2 Global Diabetes Testing Program Revenue by Manufacturers 31
3.2.1 Global Diabetes Testing Program Revenue by Manufacturers (2019-2024) 31
3.2.2 Global Diabetes Testing Program Revenue Market Share by Manufacturers (2019-2024) 32
3.2.3 Global Top 10 and Top 5 Companies by Diabetes Testing Program Revenue in 2023 33
3.3 Global Key Players of Diabetes Testing Program, Industry Ranking, 2021 VS 2022 34
3.4 Global Diabetes Testing Program Sales Price by Manufacturers (2019-2024) 35
3.5 Analysis of Competitive Landscape 36
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 36
3.5.2 Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 37
3.6 Global Key Manufacturers of Diabetes Testing Program, Manufacturing Base Distribution and Headquarters 39
3.7 Global Key Manufacturers of Diabetes Testing Program, Product Offered 39
3.8 Global Key Manufacturers of Diabetes Testing Program, Date of Enter into This Industry 40
3.9 Mergers & Acquisitions, Expansion Plans 41
4 MARKET SIZE BY TYPE 43
4.1 Global Diabetes Testing Program Sales by Type 43
4.1.1 Global Diabetes Testing Program Historical Sales by Type (2019-2024) 43
4.1.2 Global Diabetes Testing Program Forecasted Sales by Type (2025-2030) 43
4.1.3 Global Diabetes Testing Program Sales Market Share by Type (2019-2030) 44
4.2 Global Diabetes Testing Program Revenue by Type 45
4.2.1 Global Diabetes Testing Program Historical Revenue by Type (2019-2024) 45
4.2.2 Global Diabetes Testing Program Forecasted Revenue by Type (2025-2030) 45
4.2.3 Global Diabetes Testing Program Revenue Market Share by Type (2019-2030) 45
4.3 Global Diabetes Testing Program Price by Type 46
4.3.1 Global Diabetes Testing Program Price by Type (2019-2024) 46
4.3.2 Global Diabetes Testing Program Price Forecast by Type (2025-2030) 47
5 MARKET SIZE BY APPLICATION 48
5.1 Global Diabetes Testing Program Sales by Application 48
5.1.1 Global Diabetes Testing Program Historical Sales by Application (2019-2024) 48
5.1.2 Global Diabetes Testing Program Forecasted Sales by Application (2025-2030) 48
5.1.3 Global Diabetes Testing Program Sales Market Share by Application (2019-2030) 49
5.2 Global Diabetes Testing Program Revenue by Application 50
5.2.1 Global Diabetes Testing Program Historical Revenue by Application (2019-2024) 50
5.2.2 Global Diabetes Testing Program Forecasted Revenue by Application (2025-2030) 50
5.2.3 Global Diabetes Testing Program Revenue Market Share by Application (2019-2030) 50
5.3 Global Diabetes Testing Program Price by Application 52
5.3.1 Global Diabetes Testing Program Price by Application (2019-2024) 52
5.3.2 Global Diabetes Testing Program Price Forecast by Application (2025-2030) 52
6 US & CANADA 53
6.1 US & Canada Diabetes Testing Program Market Size by Type 53
6.1.1 US & Canada Diabetes Testing Program Sales by Type (2019-2030) 53
6.1.2 US & Canada Diabetes Testing Program Revenue by Type (2019-2030) 54
6.2 US & Canada Diabetes Testing Program Market Size by Application 55
6.2.1 US & Canada Diabetes Testing Program Sales by Application (2019-2030) 55
6.2.2 US & Canada Diabetes Testing Program Revenue by Application (2019-2030) 56
6.3 US & Canada Diabetes Testing Program Market Size by Country 58
6.3.1 US & Canada Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030 58
6.3.2 US & Canada Diabetes Testing Program Revenue by Country (2019-2030) 58
6.3.3 US & Canada Diabetes Testing Program Sales by Country (2019-2030) 59
6.3.4 US 60
6.3.5 Canada 61
7 EUROPE 62
7.1 Europe Diabetes Testing Program Market Size by Type 62
7.1.1 Europe Diabetes Testing Program Sales by Type (2019-2030) 62
7.1.2 Europe Diabetes Testing Program Revenue by Type (2019-2030) 63
7.2 Europe Diabetes Testing Program Market Size by Application 64
7.2.1 Europe Diabetes Testing Program Sales by Application (2019-2030) 64
7.2.2 Europe Diabetes Testing Program Revenue by Application (2019-2030) 65
7.3 Europe Diabetes Testing Program Market Size by Country 66
7.3.1 Europe Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030 66
7.3.2 Europe Diabetes Testing Program Revenue by Country (2019-2030) 67
7.3.3 Europe Diabetes Testing Program Sales by Country (2019-2030) 68
7.3.4 Germany 70
7.3.5 France 70
7.3.6 U.K. 71
7.3.7 Italy 71
7.3.8 Russia 72
8 CHINA 73
8.1 China Diabetes Testing Program Market Size by Type 73
8.1.1 China Diabetes Testing Program Sales by Type (2019-2030) 73
8.1.2 China Diabetes Testing Program Revenue by Type (2019-2030) 74
8.2 China Diabetes Testing Program Market Size by Application 75
8.2.1 China Diabetes Testing Program Sales by Application (2019-2030) 75
8.2.2 China Diabetes Testing Program Revenue by Application (2019-2030) 76
9 ASIA (EXCLUDING CHINA) 78
9.1 Asia Diabetes Testing Program Market Size by Type 78
9.1.1 Asia Diabetes Testing Program Sales by Type (2019-2030) 78
9.1.2 Asia Diabetes Testing Program Revenue by Type (2019-2030) 79
9.2 Asia Diabetes Testing Program Market Size by Application 80
9.2.1 Asia Diabetes Testing Program Sales by Application (2019-2030) 80
9.2.2 Asia Diabetes Testing Program Revenue by Application (2019-2030) 81
9.3 Asia Diabetes Testing Program Market Size by Region 82
9.3.1 Asia Diabetes Testing Program Revenue by Region: 2019 VS 2023 VS 2030 82
9.3.2 Asia Diabetes Testing Program Revenue by Region (2019-2030) 82
9.3.3 Asia Diabetes Testing Program Sales by Region (2019-2030) 83
9.3.4 Japan 85
9.3.5 South Korea 85
9.3.6 Southeast Asia 86
9.3.7 India 86
9.3.8 Australia 87
10 MIDDLE EAST, AFRICA AND LATIN AMERICA 88
10.1 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Type 88
10.1.1 Middle East, Africa and Latin America Diabetes Testing Program Sales by Type (2019-2030) 88
10.1.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Type (2019-2030) 89
10.2 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Application 90
10.2.1 Middle East, Africa and Latin America Diabetes Testing Program Sales by Application (2019-2030) 90
10.2.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Application (2019-2030) 91
10.3 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Country 93
10.3.1 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030 93
10.3.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country (2019-2030) 93
10.3.3 Middle East, Africa and Latin America Diabetes Testing Program Sales by Country (2019-2030) 95
10.3.4 Brazil 96
10.3.5 Mexico 97
10.3.6 Turkey 97
10.3.7 Israel 98
10.3.8 GCC Countries 98
11 CORPORATE PROFILE 99
11.1 Abbott Laboratories 99
11.1.1 Abbott Laboratories Company Information 99
11.1.2 Abbott Laboratories Overview 99
11.1.3 Abbott Laboratories Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 100
11.1.4 Abbott Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 100
11.1.5 Abbott Laboratories Recent Developments 101
11.2 Roche 102
11.2.1 Roche Company Information 102
11.2.2 Roche Overview 102
11.2.3 Roche Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 103
11.2.4 Roche Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 103
11.2.5 Roche Recent Developments 105
11.3 Siemens 106
11.3.1 Siemens Company Information 106
11.3.2 Siemens Overview 106
11.3.3 Siemens Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 107
11.3.4 Siemens Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 108
11.3.5 Siemens Recent Developments 108
11.4 LifeScan 109
11.4.1 LifeScan Company Information 109
11.4.2 LifeScan Overview 110
11.4.3 LifeScan Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 110
11.5 Bio-Rad Laboratories 111
11.5.1 Bio-Rad Laboratories Company Information 112
11.5.2 Bio-Rad Laboratories Overview 112
11.5.3 Bio-Rad Laboratories Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 113
11.5.4 Bio-Rad Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 113
11.5.5 Bio-Rad Laboratories Recent Developments 114
11.6 Sinocare 114
11.6.1 Sinocare Company Information 114
11.6.2 Sinocare Overview 115
11.6.3 Sinocare Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 115
11.6.4 Sinocare Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 116
11.7 Tosoh 117
11.7.1 Tosoh Company Information 118
11.7.2 Tosoh Overview 118
11.7.3 Tosoh Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 119
11.7.4 Tosoh Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 120
11.7.5 Tosoh Recent Developments 120
11.8 Ascensia 121
11.8.1 Ascensia Company Information 121
11.8.2 Ascensia Overview 122
11.8.3 Ascensia Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 122
11.8.4 Ascensia Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 123
11.9 Danaher Corporation 124
11.9.1 Danaher Corporation Company Information 124
11.9.2 Danaher Corporation Overview 125
11.9.3 Danaher Corporation Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 126
11.9.4 Danaher Corporation Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 126
11.9.5 Danaher Corporation Recent Developments 127
11.10 Trinity Biotech 128
11.10.1 Trinity Biotech Company Information 128
11.10.2 Trinity Biotech Overview 128
11.10.3 Trinity Biotech Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 130
11.10.4 Trinity Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 130
11.10.5 Trinity Biotech Recent Developments 131
11.11 Acon Biotech 132
11.11.1 Acon Biotech Company Information 132
11.11.2 Acon Biotech Overview 132
11.11.3 Acon Biotech Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 133
11.11.4 Acon Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 133
11.12 Terumo 134
11.12.1 Terumo Company Information 135
11.12.2 Terumo Overview 135
11.12.3 Terumo Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 136
11.12.4 Terumo Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 137
11.12.5 Terumo Recent Developments 138
11.13 Arkray 139
11.13.1 Arkray Company Information 139
11.13.2 Arkray Overview 139
11.13.3 Arkray Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 140
11.13.4 Arkray Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 140
11.14 HUMAN Diagnostics 142
11.14.1 HUMAN Diagnostics Company Information 142
11.14.2 HUMAN Diagnostics Overview 142
11.14.3 HUMAN Diagnostics Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 143
11.14.4 HUMAN Diagnostics Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 143
11.15 Braun 144
11.15.1 Braun Company Information 144
11.15.2 Braun Overview 145
11.15.3 Braun Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 145
11.15.4 Braun Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 146
11.15.5 Braun Recent Developments 147
11.16 I-SENS 147
11.16.1 I-SENS Company Information 147
11.16.2 I-SENS Overview 148
11.16.3 I-SENS Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 148
11.16.4 I-SENS Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 148
11.16.5 I-SENS Recent Developments 149
11.17 Omron 150
11.17.1 Omron Company Information 150
11.17.2 Omron Overview 150
11.17.3 Omron Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 151
11.17.4 Omron Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 151
11.17.5 Omron Recent Developments 152
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 154
12.1 Diabetes Testing Program Industry Chain Analysis 154
12.2 Diabetes Testing Program Key Raw Materials 155
12.2.1 Key Raw Materials 155
12.2.2 Raw Materials Key Suppliers 155
12.3 Diabetes Testing Program Production Mode & Process 156
12.4 Diabetes Testing Program Sales and Marketing 157
12.4.1 Diabetes Testing Program Sales Channels 157
12.4.2 Diabetes Testing Program Distributors 157
12.5 Diabetes Testing Program Customers 158
13 DIABETES TESTING PROGRAM MARKET DYNAMICS 159
13.1.1 Diabetes Testing Program Industry Trends 159
13.1.2 Diabetes Testing Program Market Drivers 160
13.1.3 Diabetes Testing Program Market Challenges 161
13.1.4 Diabetes Testing Program Market Restraints 162
14 KEY FINDINGS IN THE GLOBAL DIABETES TESTING PROGRAM STUDY 163
15 APPENDIX 164
15.1 Research Methodology 164
15.1.1 Methodology/Research Approach 164
15.1.2 Data Source 167
15.2 Author Details 170
15.3 Disclaimer 170

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（diabetes）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/10/04　10:27

147.72 円

163.39 円

196.69 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.